1. Home
  2. CTKB vs ABCL Comparison

CTKB vs ABCL Comparison

Compare CTKB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • ABCL
  • Stock Information
  • Founded
  • CTKB 1990
  • ABCL 2012
  • Country
  • CTKB United States
  • ABCL Canada
  • Employees
  • CTKB N/A
  • ABCL N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTKB Health Care
  • ABCL Health Care
  • Exchange
  • CTKB Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • CTKB 708.8M
  • ABCL 841.8M
  • IPO Year
  • CTKB 2021
  • ABCL 2020
  • Fundamental
  • Price
  • CTKB $6.27
  • ABCL $2.85
  • Analyst Decision
  • CTKB Strong Buy
  • ABCL Buy
  • Analyst Count
  • CTKB 3
  • ABCL 3
  • Target Price
  • CTKB $9.17
  • ABCL $8.50
  • AVG Volume (30 Days)
  • CTKB 646.8K
  • ABCL 2.6M
  • Earning Date
  • CTKB 11-05-2024
  • ABCL 02-18-2025
  • Dividend Yield
  • CTKB N/A
  • ABCL N/A
  • EPS Growth
  • CTKB N/A
  • ABCL N/A
  • EPS
  • CTKB N/A
  • ABCL N/A
  • Revenue
  • CTKB $201,210,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • CTKB $8.18
  • ABCL N/A
  • Revenue Next Year
  • CTKB $13.21
  • ABCL $36.56
  • P/E Ratio
  • CTKB N/A
  • ABCL N/A
  • Revenue Growth
  • CTKB 9.88
  • ABCL N/A
  • 52 Week Low
  • CTKB $4.66
  • ABCL $2.34
  • 52 Week High
  • CTKB $9.87
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 45.80
  • ABCL 50.52
  • Support Level
  • CTKB $6.11
  • ABCL $2.62
  • Resistance Level
  • CTKB $6.78
  • ABCL $3.05
  • Average True Range (ATR)
  • CTKB 0.33
  • ABCL 0.17
  • MACD
  • CTKB -0.09
  • ABCL -0.02
  • Stochastic Oscillator
  • CTKB 13.95
  • ABCL 49.46

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: